chrisvoncsefalvay/vaers-outcomes huggingface dataset:
my arm was sore and red; I had a slight headache after the first vaccine, which resolved quickly; This is a spontaneous report received from a contactable consumer or other non hcp. A 67-years-old male patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: EL3247), via an unspecified route of administration, administered in Arm Right on 29Jan2021,at the age of 67 years old, as Dose 1,single for covid-19 immunization.Medical history included cardiovascular disorder, asthma, hypertension and drug hypersensitivity from an unknown date and unknown if ongoing.Concomitant medication(s) included metoprolol; rosuvastatin,tamsulosin and acetylsalicylic acid (ASPIRIN (E.C.)) taken for an unspecified indication,start and stop date were not reported.The patient experienced my arm was sore and red on an unspecified date, he had a slight headache after the first vaccine, which resolved quickly on an unspecified date.The patient received his 2nd dose of Pfizer covid19 vaccine on 19 feb2021,11:15 am.The patient had not received any other vaccine in 4 weeks.The patient was not diagnosed with covid prior to vaccination and not tested post vaccination.The patient had not received any treatment for the event.The outcome of the event was recovered.  Follow-up (12May2021): Follow-up attempts completed. No further information is expected.
Information has been received from a medical assistant concerning a 42 year old female with SEPTRA allergy and no pertinent medical history who on 19-JUN-2009 was vaccinates subcutaneously with the first 0.5ml dose of VARIVAX (Merck) (lot# 663709/0193Y). Concomitant therapy included trazodone HCl, thyroid medication, birth control pills and anti-inflammatory medications. On 21-JUN-2009 ("two days after vaccination") the patient developed injection site reaction. The patient had the raised "knot" the size of a quarter and the injection site redness was the size of "50 cents". No medical attention was sought. The reaction lasted about 4 days. On approximately 25-JUN-2009 the patient recovered. No further information is available.
Rapid and irregular heart rate; Cold sweats; Mild chest pain; Headache; Fatigue; Chills; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 02Apr2021 at 09:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, asthma, obesity and gerd (Gastroesophageal reflux disease); all from unknown dates. The patient had known allergy to aggrandizing. The patient received unspecified medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via an unspecified route of administration in the right arm on 05Mar2021 at 09:15 (at the age of 66-years-old) as a single dose for COVID-19 immunisation and erythromycin (MANUFACTURER UNKNOWN), tetracycline (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 13:00, the patient experienced rapid and irregular heart rate, cold sweats, mild chest pain, headache, fatigue, chills, nausea, vomiting and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events rapid and irregular heart rate, cold sweats, mild chest pain, headache, fatigue, chills, nausea, vomiting and diarrhea was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a registered nurse referring to a patient of unknown age and gender. Patient's concurrent or historical condition was not provided. On 09-JUN-2016 the patient was inadvertently vaccinated with an expired dose of M-M-R II (lot # K008198 with expired date of 05-JUN-2016, once and strength unknown) subcutaneously. Concomitant therapy was not provided. No adverse effects were reported. Additional information has been requested.
Per nurse at PMD's office, infant was seen by PMD on 4/10/01 with diffuse rash from head to toe. Scalp had rash, but face did not. Infant had "low-grade" fever the evening of 4/9/01. PMD provided no treatment but indicated to mom that it was probably vaccine related. Still has rash.
Patient received DaTP immunization on 3/23/04 at 4pm on the left deltoid and returned on 3/25/04 at 3pm for local reaction check. Seen by charge nurse. Injection site was swollen, red. Advised for local compresses. No fever. Retrun to see MD if needed.
Systemic: Fainting / Unresponsive-Medium, Additional Details: Pt fainted about 2-3 minutes post vaccination, was un-responsive for 5-7 minutes,  Pulse and breathing were normal, paramedics arrived and checked her out.  she ended up leaving with her mother.
Pt mother called and said that 5/25/2022 at 8pm he started running a temp of 103. She gave motrin and it would go back down.  He has no other symptoms. 5/26/2022 she noticed a raised warm red area at the injection site.
pt recv vax & w/in 24hr post vax pt exp stiffness & pain in rt arm inj site;additionally was hardly able to lift arm had a pain in neck & a migraine h/a;reporter stated that the pain set off the migraine h/a;
Rash with itching noted to left armpit and left back 5 days after vaccination.  Employee presents to Employee Health on 7/5/07 and placed on Administrative Leave.  Employee rec'd follow-up care from PCP beginning 7/9/07.  PCP diagnosis of Herpes Zoster.  Treatment includes Acyclovir, Tylenol and Benedryl.  Employee with continued rash/itching at time of this writing.  Employee advised by PCP against having 2nd Varicella vaccination in 30 days.
my whole right side is numb; right side is numb/tingling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (my whole right side is numb) and PARAESTHESIA (right side is numb/tingling) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (my whole right side is numb) and PARAESTHESIA (right side is numb/tingling). At the time of the report, HYPOAESTHESIA (my whole right side is numb) and PARAESTHESIA (right side is numb/tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Getting short breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Getting short breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Getting short breath). At the time of the report, DYSPNOEA (Getting short breath) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medication was reported.  No treatment medication use was reported.
Case was vaccinated for Covid by January 2021, then hospitalized for Covid in January 2022. Hospitalized at: Hospital.   Onset 1/23/22, where he tested positive and was treated with Molnupiravir.  He was then Hospitalized 1/31/22 for Cough, sore throat, N/V, headache, fever, tachycardia, and bilateral lung opacities.   Started on dexamethasone, but d/c'd due to rash. No further Covid treatments, but continued on hydrocortisone for other issues.
I received the shingles vaccine at my doctor's office on Oct. 10, 2009 during a routine yearly physical. On Nov.11, 2009 I woke up with a noise in my left ear and eventual deafness in that ear. I experienced abnormal constipation and became extremely dizzy and had the dry heaves. My husband came home and took me to my doctor. I am deaf in my left ear and experiencing various loud noises in my head.
Initial misuse report received from a healthcare professional on 10 December 2013. The patient had received ACT HIB and was reconstituted with sterile water instead of supplied diluent. (No information was provided regarding the patient). No adverse event ws reported. List of documents held by sender: none.
About 4 weeks after taking the vaccine patient notice that her hair was falling out.  She also noticed that her mouth was a little twisted at the bottom. Patient also noticed that she has lymphnodes behind her right ear and two under her right arm. Patient also stated that she feels a tingle in her toes and it seems like she has electricity in her toes.
fever 103-104 24 hrs, 4 hrs post DTP inoculation 7MAR94;
No other AE reported; Patient administered PROQUAD that expired; This spontaneous report as received from a nurse refers to a 5-year-old patient of unknown gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.   On 01-FEB-2021, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot number: S022916, expiration date: 19-JAN-2021; route of administration was not provided) 0.5 ml. No adverse event was reported.
Rash, Fever, Headache - Information has been received from a physician concerning a 15 year old black male with behavioral problems and no known drug allergies who on 06 Nov 2000 was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation 636660/1127K.  The physician reported that on 06 Nov 2000 at 5pm, the patient developed a maculopapular rash of about 40-50 papules isolated to the torso 4 hours after receiving the vaccine.  The physician reported that pallative measures were administered by the patient's mother tetaminophen (tylenol) for headache/fever and bed rest.  The physicain reported that the patient recovered 10 Nov 2000.  No further information is available.
This spontaneous report as received from a physician via a sales representative refers to a 22-year-old female patient. Information about concurrent conditions and medical history was not provided. On 20-JUL-2009 the patient was vaccinated with the first dose of GARDASIL (route, lot, batch # and expiration date not reported) as routine administration. Patient's second dose was on 14-SEP-2009 and third dose was 29-DEC-2009. Co-suspect and concomitant therapies were not reported. On 07-JAN-2014, 1633 days after onset of therapy, an unspecified test result showed she had a high risk for HPV after receiving the 3 series doses of GARDASIL. The patient sought medical attention. The outcome was unknown. Additional information has been requested.
HEART PALPITATIONS LASTED ALMOST 5 MONTHS; COULD NOT EVEN WALK ONE MILE AFTER BEING VACCINATED; DIZZINESS IF TRIED TO EXERT LASTED ALMOST 5 MONTHS / DIZZY IF ANYTHING THAT ACCELERATED HEART RATE; CHIN WAS ONE BIG HERPES SORE; COULD NOT MOVE THE INJECTED ARM AWAY FROM BODY FOR MONTHS WITHOUT PAIN; NAUSEOUS IF ANYTHING THAT ACCELERATED HEART RATE; HEADACHE STARTING 2 HOURS POST VACCINATION LASTING ALMOST 2 WEEKS; FATIGUE WAS DEBILITATING; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient walked 8 miles in the mountains just prior to the vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced heart palpitations lasted almost 5 months, could not even walk one mile after being vaccinated, dizziness if tried to exert lasted almost 5 months / dizzy if anything that accelerated heart rate, chin was one big herpes sore, could not move the injected arm away from body for months without pain, nauseous if anything that accelerated heart rate, headache starting 2 hours post vaccination lasting almost 2 weeks, and fatigue was debilitating. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart palpitations lasted almost 5 months, dizziness if tried to exert lasted almost 5 months / dizzy if anything that accelerated heart rate, could not move the injected arm away from body for months without pain, and headache starting 2 hours post vaccination lasting almost 2 weeks, and the outcome of could not even walk one mile after being vaccinated, fatigue was debilitating, chin was one big herpes sore and nauseous if anything that accelerated heart rate was not reported. This report was non-serious. This case, from the same reporter is linked to 20230103826.
Initial report was received from a consumer (patient) on 22 Dec 2009: This patient received S-OIV FLUVIRIN on an unknown date. After a few hours of vaccination patient could not open her mouth or jaw. It was reported that after a couple of minutes patient was able to open her mouth little by little. Patient's mouth was hurt and she couldn't open her jaw without having a popping sound. The outcome of the event was not reported.
Patient diagnosed with Leukemia.; Blood work done shortly (1-2 weeks) after the vaccine, showed lowered platelet count.  Previous tests had always been normal (most recent being in Nov 2020). Subsequent blood work continued to show lo; This is a spontaneous report from a Contactable consumer (patient). A 79-year-old male patient received an unknown dose of BNT162B2 via an unspecified route of administration in May2021 at the age of 79-year-old as single dose for COVID-19 immunization. Medical history included Rheumatoid arthritis. The patient did not received other vaccine in four weeks. The patient was not COVID prior vaccination. The patient did not tested COVID post vaccination. Concomitant medication was not reported. In May2021, the patient diagnosed with Leukemia, blood work done shortly (1-2 weeks) after the vaccine, showed lowered platelet count. Previous tests had always been normal (most recent being in Nov 2020). Subsequent blood work continued to show lowered platelet counts. Previous tests had always been normal (most recent being in Nov2020). Ae resulted in doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event). The outcome of events was unknown.  The lot number for BNT162B2, was not provided and will be requested during follow up.
dizziness, slurred speech, unstable gait, fatigue, burning sensation to eyelids
Redness and swelling of entire upper arm. 2 days after administration, a fluid filled blister (3cm x 1.5cm) developed. 3 days after administration, the redness and swelling began to decrease.
Just a sore arm in the area of injection; This is a spontaneous report from a contactable consumer (patient). A 73-years-old female patient received first dose of bnt162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL9262, expiration: not reported), via an unspecified route of administration, administered in arm left on 28Jan2021 13:45 as single dose for Covid-19 immunization (at the age of 73-years and the patient was not pregnant). Medical history included diabetes from an unknown date and unknown if ongoing, kidney function from an unknown date and unknown if ongoing. Concomitant medication(s) included triamterene taken for an unspecified indication, start and stop date were not reported; valsartan taken for an unspecified indication, start and stop date were not reported; atorvastatin taken for an unspecified indication, start and stop date were not reported; metoprolol taken for an unspecified indication, start and stop date were not reported (all as other medications in two weeks). No other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. On 29Jan2021, the patient experienced just a sore arm in the area of injection. No treatment taken for event. The outcome for event was recovering.   No follow up attempts are possible. No further information is expected.
Death of a patient the day after taking the Fluad Quad vaccine; This spontaneous case was received on 22-Sep-2023, from other healthcare professional via Communications (reference number: SEQW23-02546) and concerned a patient with unspecified age and gender.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose, route of administration, anatomical location, and indication: not reported). The batch number was not reported.   On an unspecified date, reported as 'the day after' receiving Fluad Quadrivalent, the patient died. The cause of death and information on whether an autopsy was performed, were not provided.  The reporter did not provide a causality assessment.  The event of death was considered serious due to the seriousness criteria of a fatal outcome. Additionally, the event of death was considered to be medically significant by a Physician within CSL Seqirus's Pharmacovigilance Department.  Company comment: A patient with unspecified age and gender was vaccinated with Fluad Quadrivalent. On an unspecified date, reported as 'the day after' vaccination, the patient died. The cause of death was not reported, and it was not reported if an autopsy was performed. The patient's medical history and concomitant medications were not reported. Information regarding relevant laboratory findings and diagnostic data was not reported. Causal role of the suspect vaccine is unassessable for the event death, due to lack of information provided.; Sender's Comments: A patient with unspecified age and gender was vaccinated with Fluad Quadrivalent. On an unspecified date, reported as 'the day after' vaccination, the patient died. The cause of death was not reported, and it was not reported if an autopsy was performed. The patient's medical history and concomitant medications were not reported. Information regarding relevant laboratory findings and diagnostic data was not reported. Causal role of the suspect vaccine is unassessable for the event death, due to lack of information provided.; Reported Cause(s) of Death: Death of a patient the day after taking the Fluad Quad vaccine
Pins and needles for 11 weeks/left side of face tingling/left arm started tingling and also left leg; Ringing in my ears; Cherry angiomas type marks all over body; This is a spontaneous report received from a contactable consumer (patient). A 40-year-old non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot #: ER8729) via an unspecified route of administration on 09Apr2021 at 10:45 (at the age of 40-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was reported as none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported; however, it was reported that there were no other medications taken within two weeks of the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced pins and needles for 11 weeks/left side of face tingling/left arm started tingling and also left leg and on an unspecified date in Apr2021, the patient experienced ringing in my ears and cherry angiomas type marks all over body. The events were reported as serious for disability or permanent damage. The clinical course was reported as follows: The patient's left side of face started tingling within 15 minutes of getting the shot. On the next day, her left arm started tingling and also left leg. She also had ringing in her ears. The patient also stated that she has had pins and needles for 11 weeks post vaccine. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. Treatment was received for the adverse events and was unspecified. The patient was tested for COVID-19 post vaccination on Jul2021 (nasal swab; PCR) which was negative. The clinical outcomes of the events pins and needles for 11 weeks/left side of face tingling/left arm started tingling and also left leg, ringing in my ears and cherry angiomas type marks all over body were not recovered/ not resolved.
Auditing charts and discovered IPV lot # written down by MA on 5-11-07 was an incorrect lot#, upon investigation, discovered that the lot # was for PPD. MA gave PPD 0.5 ml SQ to patient. Patient had not had any adverse effects at this time.
he started bleeding from the injection site and bled a good amount; This is a spontaneous report from a contactable consumer (patient's spouse). An adult male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown) via an unspecified route of administration administered in the left arm on 10Apr2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. The patient did not have covid prior vaccination. The spouse informed that when the patient got his vaccine today, 10Apr2021, he started bleeding from the injection site and bled a good amount and he was concerned that the vaccine came out with his bleeding. The spouse and the patient wanted to know if the Pfizer covid-19 leaks out of the injection site. They both wanted to know if this was possible and; to let them know how it works to put them at ease or; let them know if the patient needed another first dose. No treatment was received for the adverse event reported. The outcome of the adverse event was unknown. The patient has not been covid-tested post-vaccination.   Information about the batch/lot no has been requested.
Patient had received monoclonal antibodies (bamlanivimab) 09JAN22.  Patient then received a Moderna booster 20JAN22.  Patient unknowingly filled the form incorrectly prior to receiving Moderna.
On the 1/24/2021 I woke up 10pm and I noticed my left side of my face was swollen as well my eye lid and a couple of hours after  my left side of my neck was swollen as well. On 1/25/2021 I went to see my doctor and he gave me antihistamine. He said to take it until I get my 2nd dose. I also took Benadryl. By 1/25/2021 evening it had resolved.
I had a tremendous headache, dizzy I had hold on to the wall to help me walk, nauseous when I was moving around, and very limp. This lasted for 24 hours. The next day I took ADVIL. I started to feel better, but I was fatigue for the first week.
Developed palpitations approximately one week after both doses.  The palpitations were new to the patient as she has no history of palpitations.  Episodes came and went for a week.  No dizziness or shortness of breath or chest pain.